Searched for
PSORIATIC ARTHRITIS MANAGEMENT
Kim Kardashian’s 16-pound weight loss in 3 weeks: What she did, what it costs, and what you should really knowWhen Kim Kardashian announced she lost 16 pounds in three weeks to wear Marilyn Monroe’s iconic “Happy Birthday Mr President” dress for the...- Biocon gets Health Canada nod for biosimilars Yesintek, Yesintek IVBiocon Biologics has made strides in the healthcare sector by obtaining Health Canada’s approval for Yesintek and Yesintek IV, its latest a...
- Psoriatic Arthritis explained: Early signs, causes, and how to stop joint damage before it startsPsoriatic arthritis affects skin and joints with inflammation. This autoimmune condition causes pain, stiffness, and swelling. Early detect...
- Biocon Biologics secures multiple market access agreements in US for YesintekBiocon Biologics' Yesintek, a biosimilar to Stelara, has secured significant market access in the US, covering over 100 million lives. Mult...
- Biocon shares in focus after subsidiary launches biosimilar alternative to Stelara in the USBiocon Biologics has launched YESINTEK, a biosimilar to Stelara, in the United States for treating chronic autoimmune conditions, offering ...
- Biocon settles with Janssen to commercialise biosimilar products in Europe, Canada, JapanBiocon Biologics has entered into a settlement and licence agreement with Janssen Biotech Inc, Janssen Sciences Ireland, and Johnson & John...
- World Arthritis Day 2023: Types of arthritis, symptoms, treatment and self-care tipsWorld Arthritis Day observed on October 12 each year, aims to raise awareness of rheumatic and musculoskeletal diseases (RMDs). This year's...
- Eli Lilly forays into dermatological space with launch of psoriasis drugEli Lilly has launched a new drug to treat moderate-to-severe plaque psoriasis in India. The drug, Copellor, is designed to specifically ta...
- Sun Pharma arm enters pact with China Medical SystemChina Medical System will pay Sun Pharma an initial upfront payment, regulatory and sales milestone payments, and royalties on net sales, t...
- Big pharma returning to US price hikes in January after pausePfizer has already announced plans to hike prices on 41 of its drugs in mid-January.
- Lupin aims to be numero uno in biosimilar etanercept in JapanIt takes 12-13 months for the Japanese drug authorities to give product approvals.
- Zydus Cadila launches biosimilar of AbbVie's Humira in IndiaZydus Cadila today launched biosimilar of Adalimumab, used for treatment of auto immune disorders, at a price much lower than the innovator...
- Ranbaxy launches arthritis drug Infimab in IndiaInfimab has been introduced in the Indian market through a licensing partnership with Epirus Biopharmaceuticals, Ranbaxy said in a statemen...
- Cipla launches biosimilar for rheumatic disorders in IndiaDrug major Cipla said it has launched biosimilar of Etanercept under the brand name 'Etacept' used for treatment of rheumatic disorders in ...
Load More
